LinkedIn

 آمار

تعداد نشریات20
تعداد شماره‌ها1,125
تعداد مقالات10,314
تعداد مشاهده مقاله43,473,779
تعداد دریافت فایل اصل مقاله9,718,852
Naderi-boldaji, Vida, Zand, Farid, Asmarian, Naeimehossadat, Marbooti, Hoda, Masjedi, Mansoor, Tabibzadeh, Seyedeh Maryam, Esmaeilinezhad, Zahra, Nazeri, Masoume. (1403). Clinical Characteristics and Prognosis of ICU-Admitted Patients with Guillain-Barre Syndrome: A Report from a Large Teaching Hospital in South Iran. سامانه مدیریت نشریات علمی, 49(8), 501-507. doi: 10.30476/ijms.2023.99401.3144
Vida Naderi-boldaji; Farid Zand; Naeimehossadat Asmarian; Hoda Marbooti; Mansoor Masjedi; Seyedeh Maryam Tabibzadeh; Zahra Esmaeilinezhad; Masoume Nazeri. "Clinical Characteristics and Prognosis of ICU-Admitted Patients with Guillain-Barre Syndrome: A Report from a Large Teaching Hospital in South Iran". سامانه مدیریت نشریات علمی, 49, 8, 1403, 501-507. doi: 10.30476/ijms.2023.99401.3144
Naderi-boldaji, Vida, Zand, Farid, Asmarian, Naeimehossadat, Marbooti, Hoda, Masjedi, Mansoor, Tabibzadeh, Seyedeh Maryam, Esmaeilinezhad, Zahra, Nazeri, Masoume. (1403). 'Clinical Characteristics and Prognosis of ICU-Admitted Patients with Guillain-Barre Syndrome: A Report from a Large Teaching Hospital in South Iran', سامانه مدیریت نشریات علمی, 49(8), pp. 501-507. doi: 10.30476/ijms.2023.99401.3144
Naderi-boldaji, Vida, Zand, Farid, Asmarian, Naeimehossadat, Marbooti, Hoda, Masjedi, Mansoor, Tabibzadeh, Seyedeh Maryam, Esmaeilinezhad, Zahra, Nazeri, Masoume. Clinical Characteristics and Prognosis of ICU-Admitted Patients with Guillain-Barre Syndrome: A Report from a Large Teaching Hospital in South Iran. سامانه مدیریت نشریات علمی, 1403; 49(8): 501-507. doi: 10.30476/ijms.2023.99401.3144

Clinical Characteristics and Prognosis of ICU-Admitted Patients with Guillain-Barre Syndrome: A Report from a Large Teaching Hospital in South Iran

Iranian Journal of Medical Sciences
مقاله 5، دوره 49، شماره 8، آبان 2024، صفحه 501-507    اصل مقاله (356.94 K)
نوع مقاله: Original Article(s)
شناسه دیجیتال (DOI): 10.30476/ijms.2023.99401.3144
نویسندگان
Vida Naderi-boldaji1؛ Farid Zand1؛ Naeimehossadat Asmarian1؛ Hoda Marbooti2؛ Mansoor Masjedi1؛ Seyedeh Maryam Tabibzadeh1؛ Zahra Esmaeilinezhad1؛ Masoume Nazeri* 2
1Anesthesiology and Critical Care Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
2Epilepsy Research Center, Shiraz University of Medical Sciences, Shiraz, Iran
چکیده
Background: Guillain-Barre Syndrome (GBS) is the most prevalent acute peripheral polyneuropathy disorder. The disparities between populations and variations in the major risk factors highlight the importance of country-specific studies. This study aimed to report clinical characteristics and outcomes of ICU-admitted patients with GBS in an academic medical center in Iran. 
Methods: The data were collected retrospectively from all patients with GBS admitted to Namazi Hospital, affiliated with Shiraz University of Medical Sciences, (Shiraz, Iran), between March 2016 to March 2021. Specialized neurological information and the Acute Physiology and Chronic Health Evaluation (APACHE II) score were recorded. The SPSS software was used to analyze the data. The analyzed data were reported as numbers and percentages, or mean±SD, or median(Interquartile) 
Results: The study included 132 GBS patients, with an average age of 47.87±15.4 years and a male-to-female ratio of 1.69:1. More than half of the patients (58.5%) were classified as having an axonal disease. In patients with axonal illness, 51.4% of patients had lower limb powers<3, while only 36% of those had the demyelinating disease. This group also required mechanical ventilation more frequently (54% vs. 46%) and for a longer duration (26 [9–37] vs. 10 [1–61]) days. Pneumonia and sepsis were each observed in 16% of patients, and 12% developed a urinary tract infection. The most common type of GBS was acute inflammatory demyelinating polyneuropathy (AIDP). Only 6 (3.8%) patients died.
Conclusion: The axonal type of GBS was more frequent, and these patients required mechanical ventilation more frequently and for a longer duration than those in other electrophysiological categories. 
کلیدواژه‌ها
Guillain-Barre syndrome؛ APACHE II؛ Immunoglobulins, intravenous
سایر فایل های مرتبط با مقاله
مراجع
  1. Kilic B, Gungor S, Ozgor B. Clinical, electrophysiological findings and evaluation of prognosis of patients with Guillain-Barre syndrome. Turk J Pediatr. 2019;61:200-8. doi: 10.24953/turkjped.2019.02.008. PubMed PMID: 32077646.
  2. Ohnari K, Okada K, Mafune K, Kusunoki S, Adachi H. Unclassified subtype of Guillain-Barre syndrome is associated with quick recovery. J Clin Neurosci. 2021;91:313-8. doi: 10.1016/j.jocn.2021.07.025. PubMed PMID: 34373045.
  3. Leonhard SE, Conde RM, de Assis Aquino Gondim F, Jacobs BC. Diagnosis and treatment of Guillain-Barre syndrome during the Zika virus epidemic in Brazil: A national survey study. J Peripher Nerv Syst. 2019;24:340-7. doi: 10.1111/jns.12358. PubMed PMID: 31746070; PubMed Central PMCID: PMCPMC6972698.
  4. Ancona P, Bailey M, Bellomo R. Characteristics, incidence and outcome of patients admitted to intensive care unit with Guillain-Barre syndrome in Australia and New Zealand. J Crit Care. 2018;45:58-64. doi: 10.1016/j.jcrc.2018.01.016. PubMed PMID: 29413724.
  5. Kishore CK, Vijayabhaskar J, Vishnu Vardhan R, Sainaresh VV, Sriramnaveen P, Sridhar AV, et al. Management of Guillain-Barre syndrome with plasmapheresis or immunoglobulin: our experience from a tertiary care institute in South India. Ren Fail. 2014;36:732-6. doi: 10.3109/0886022X.2014.890859. PubMed PMID: 24593239.
  6. Wen P, Wang L, Liu H, Gong L, Ji H, Wu H, et al. Risk factors for the severity of Guillain-Barre syndrome and predictors of short-term prognosis of severe Guillain-Barre syndrome. Sci Rep. 2021;11:11578. doi: 10.1038/s41598-021-91132-3. PubMed PMID: 34079013; PubMed Central PMCID: PMCPMC8172857.
  7. Yonezawa N, Jo T, Matsui H, Fushimi K, Yasunaga H. Effect of Early Tracheostomy on Mortality of Mechanically Ventilated Patients with Guillain-Barre Syndrome: A Nationwide Observational Study. Neurocrit Care. 2020;33:759-68. doi: 10.1007/s12028-020-00965-9. PubMed PMID: 32291575; PubMed Central PMCID: PMCPMC7223482.
  8. Shi M, Zhu J, Deng H. Clinical Characteristics of Intravenous Injection of Monosialotetrahexosyl Ganglioside Sodium-Related Guillain-Barre Syndrome. Front Neurol. 2019;10:225. doi: 10.3389/fneur.2019.00225. PubMed PMID: 30930839; PubMed Central PMCID: PMCPMC6428729.
  9. Witsch J, Galldiks N, Bender A, Kollmar R, Bosel J, Hobohm C, et al. Long-term outcome in patients with Guillain-Barre syndrome requiring mechanical ventilation. J Neurol. 2013;260:1367-74. doi: 10.1007/s00415-012-6806-x. PubMed PMID: 23299621.
  10. Dhar R, Stitt L, Hahn AF. The morbidity and outcome of patients with Guillain-Barre syndrome admitted to the intensive care unit. J Neurol Sci. 2008;264:121-8. doi: 10.1016/j.jns.2007.08.005. PubMed PMID: 17881005.
  11. Taylor CJ, Hirsch NP, Kullmann DM, Howard RS. Changes in the severity and subtype of Guillain-Barre syndrome admitted to a specialist Neuromedical ICU over a 25 year period. J Neurol. 2017;264:564-9. doi: 10.1007/s00415-016-8380-0. PubMed PMID: 28091723; PubMed Central PMCID: PMCPMC5336542.
  12. Netto AB, Taly AB, Kulkarni GB, Uma Maheshwara Rao GS, Rao S. Complications in mechanically ventilated patients of Guillain-Barre syndrome and their prognostic value. J Neurosci Rural Pract. 2017;8:68-73. doi: 10.4103/0976-3147.193542. PubMed PMID: 28149085; PubMed Central PMCID: PMCPMC5225726.
  13. Charra B, Hachimi A, Benslama A, Motaouakkil S. Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barre syndrome. Pan Afr Med J. 2014;18:35. doi: 10.11604/pamj.2014.18.35.2911. PubMed PMID: 25368724; PubMed Central PMCID: PMCPMC4215378.
  14. Bazaraa HM, Rady HI, Mohamed SA, Rabie WA, ElAnwar NH. Initial Response and Outcome of Critically Ill Children With Guillain Barre’ Syndrome. Front Pediatr. 2019;7:378. doi: 10.3389/fped.2019.00378. PubMed PMID: 31620410; PubMed Central PMCID: PMCPMC6759753.
  15. Ng KK, Howard RS, Fish DR, Hirsch NP, Wiles CM, Murray NM, et al. Management and outcome of severe Guillain-Barre syndrome. QJM. 1995;88:243-50. PubMed PMID: 7796073.
  16. Henderson RD, Lawn ND, Fletcher DD, McClelland RL, Wijdicks EF. The morbidity of Guillain-Barre syndrome admitted to the intensive care unit. Neurology. 2003;60:17-21. doi: 10.1212/01.wnl.0000035640.84053.5b. PubMed PMID: 12530364.
  17. Damian MS, Ben-Shlomo Y, Howard R, Bellotti T, Harrison D, Griggs K, et al. The effect of secular trends and specialist neurocritical care on mortality for patients with intracerebral haemorrhage, myasthenia gravis and Guillain-Barre syndrome admitted to critical care : an analysis of the Intensive Care National Audit & Research Centre (ICNARC) national United Kingdom database. Intensive Care Med. 2013;39:1405-12. doi: 10.1007/s00134-013-2960-6. PubMed PMID: 23702638.
  18. Gonzalez P, Garcia X, Guerra A, Arango JC, Delgado H, Uribe CS, et al. Experience with Guillain-Barre syndrome in a neurological Intensive Care Unit. Neurologia. 2016;31:389-94. doi: 10.1016/j.nrl.2014.09.004. PubMed PMID: 25542501.
  19. Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC. Diagnosis of Guillain-Barre syndrome and validation of Brighton criteria. Brain. 2014;137:33-43. doi: 10.1093/brain/awt285. PubMed PMID: 24163275.
  20. Akavipat P, Thinkhamrop J, Thinkhamrop B, Sriraj W. Acute Physiology and Chronic Health Evaluation (Apache) Ii Score - the Clinical Predictor in Neurosurgical Intensive Care Unit. Acta Clin Croat. 2019;58:50-6. doi: 10.20471/acc.2019.58.01.07. PubMed PMID: 31363325; PubMed Central PMCID: PMCPMC6629196.
  21. Kleyweg RP, van der Meche FG, Schmitz PI. Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain-Barre syndrome. Muscle Nerve. 1991;14:1103-9. doi: 10.1002/mus.880141111. PubMed PMID: 1745285.
  22. Bhagat SK, Sidhant S, Bhatta M, Ghimire A, Shah B. Clinical Profile, Functional Outcome, and Mortality of Guillain-Barre Syndrome: A Five-Year Tertiary Care Experience from Nepal. Neurol Res Int. 2019;2019:3867946. doi: 10.1155/2019/3867946. PubMed PMID: 31275647; PubMed Central PMCID: PMCPMC6582782.
  23. Arami MA, Yazdchi M, Khandaghi R. Epidemiology and characteristics of Guillain-Barre syndrome in the northwest of Iran. Ann Saudi Med. 2006;26:22-7. doi: 10.5144/0256-4947.2006.22. PubMed PMID: 16521871; PubMed Central PMCID: PMCPMC6078541.
  24. Kim AY, Lee H, Lee YM, Kang HY. Epidemiological Features and Economic Burden of Guillain-Barre Syndrome in South Korea: A Nationwide Population-Based Study. J Clin Neurol. 2021;17:257-64. doi: 10.3988/jcn.2021.17.2.257. PubMed PMID: 33835747; PubMed Central PMCID: PMCPMC8053545.
  25. Sedano MJ, Orizaola P, Gallardo E, Garcia A, Pelayo-Negro AL, Sanchez-Juan P, et al. A unicenter, prospective study of Guillain-Barre syndrome in Spain. Acta Neurol Scand. 2019;139:546-54. doi: 10.1111/ane.13092. PubMed PMID: 30929269.
  26. Yakoob MY, Rahman A, Jamil B, Syed NA. Characteristics of patients with Guillain Barre Syndrome at a tertiary care centre in Pakistan, 1995-2003. J Pak Med Assoc. 2005;55:493-6. PubMed PMID: 16304870.
  27. Sharma KS, Singh R, Shah GS. Guillain Barre Syndrome: Major Cause of Acute Flaccid Paralysis in Children and Adolescents of Nepal. Journal of Nepal Paediatric Society. 2011;31. doi: 10.3126/jnps.v31i2.4065.
  28. Kalita J, Misra UK, Goyal G, Das M. Guillain-Barre syndrome: subtypes and predictors of outcome from India. J Peripher Nerv Syst. 2014;19:36-43. doi: 10.1111/jns5.12050. PubMed PMID: 24456386.
  29. Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barre syndrome: incidence and mortality rates in US hospitals. Neurology. 2008;70:1608-13. doi: 10.1212/01.wnl.0000310983.38724.d4. PubMed PMID: 18443311.
  30. Rees JH, Thompson RD, Smeeton NC, Hughes RA. Epidemiological study of Guillain-Barre syndrome in south east England. J Neurol Neurosurg Psychiatry. 1998;64:74-7. doi: 10.1136/jnnp.64.1.74. PubMed PMID: 9436731; PubMed Central PMCID: PMCPMC2169900.
  31. Ruts L, Drenthen J, Jongen JL, Hop WC, Visser GH, Jacobs BC, et al. Pain in Guillain-Barre syndrome: a long-term follow-up study. Neurology. 2010;75:1439-47. doi: 10.1212/WNL.0b013e3181f88345. PubMed PMID: 20861454.
  32. Van Koningsveld R, Van Doorn PA, Schmitz PI, Ang CW, Van der Meche FG. Mild forms of Guillain-Barre syndrome in an epidemiologic survey in The Netherlands. Neurology. 2000;54:620-5. doi: 10.1212/wnl.54.3.620. PubMed PMID: 10680793.
آمار
تعداد مشاهده مقاله: 263
تعداد دریافت فایل اصل مقاله: 230


سامانه مدیریت نشریات علمی. قدرت گرفته از سیناوب